Dr. Reddy’s Announces the Appointment of Marc Kikuchi to Lead Its Generics Business in North America

On Feb 1, 2019

Dr. Reddy’s Laboratories Ltd., (along with its subsidiaries together referred to as “Dr. Reddy’s”) announced the appointment of Marc Kikuchi as Chief Executive Officer, North America Generics. As part of the Dr. Reddy’s senior leadership team, he will be responsible for the company’s North America Generics business and will be based in Princeton office, U.S.

“Dr. Reddy’s is a great company with a wide portfolio and remarkable heritage,” explains Kikuchi. “I am excited to join Dr. Reddy’s and look forward to leveraging my past experiences to steer the Company’s new growth areas.”

Marc has 20+ years of experience in the Pharmaceutical Industry with extensive knowledge and understanding of Generics. Marc joins Dr. Reddy’s from Zydus Pharmaceuticals, Inc. where he served as CEO, Americas since 2016. Prior to joining Zydus, he held professional leadership roles of increasing responsibility with AmerisourceBergen Corporation, Medrad Inc., PRTM, Johnson & Johnson and Incyte Pharmaceuticals. Marc holds a Bachelor’s Degree in Molecular and Cell Biology with a Biochemistry emphasis from the University of California at Berkeley and Master of Business Administration from Carnegie Mellon University in Strategy, Marketing, and Operations Management.

To access more business news, visit NJB News Now.